100% Fonder med alles

The chart shows the growth of an initial investment of $10,000 in 100% Fonder med alles, comparing it to the performance of the S&P 500 index or another benchmark. All prices have been adjusted for splits and dividends. The portfolio is rebalanced Every 3 months.

Based on dividend-adjusted daily data since Nov 10, 2021, 100% Fonder med alles's average daily return is +0.03%, while the average monthly return is +0.75%. At this rate, an investment would double in approximately 7.7 years.

Historically, 55% of months were positive and 45% were negative. The best month was Jul 2022 with a return of +12.2%, while the worst month was Apr 2022 at -11.8%. The longest winning streak lasted 3 consecutive months, and the longest losing streak was 3 months.

On a daily basis, 100% Fonder med alles closed higher 37% of trading days. The best single day was Apr 9, 2025 with a return of +5.4%, while the worst single day was Apr 4, 2025 at -4.8%.

100% Fonder med alles has an annualized alpha of 0.50%, beta of 0.75, and R2 of 0.64 versus S&P 500 Index. Calculated based on daily prices since November 10, 2021.

• This portfolio participated in 76.78% of S&P 500 Index downside but only 69.83% of its upside - more exposed to losses than it benefited from rallies.

100% Fonder med alles has an expense ratio of 0.09%, which is considered low. Below, you can find the expense ratios of the portfolio's funds side by side and easily compare their relative costs.

100% Fonder med alles ranks 8 for risk / return — in the bottom 8% of Portfolios on our site. This means you're taking on significantly more risk than the returns justify. Consider whether the potential upside is worth the volatility, or explore alternatives with better risk / return profiles.

The Sharpe ratio helps investors understand how much return they're getting for the level of risk taken. A higher Sharpe ratio indicates better risk-adjusted performance, meaning more reward for each unit of risk.

The current 100% Fonder med alles Sharpe ratio is 0.40 as of Jun 13, 2026 (the value is recalculated daily), calculated over the past 12 months.

Compared to the broad market, where average Sharpe ratios range from 1.54 to 2.41, this portfolio's current Sharpe ratio places it in the bottom 25%. This suggests weaker risk-adjusted returns than most portfolios, possibly due to lower returns, higher volatility, or both. It may be worth reviewing the allocation. You can use the Portfolio Optimization tool to explore options for improving the Sharpe ratio.

The chart below shows the rolling Sharpe ratio of 100% Fonder med alles compared to the selected benchmark. This view highlights how the investment's risk-adjusted performance has changed over time.

100% Fonder med alles provided a 1.16% dividend yield over the last twelve months.

The Drawdowns chart displays portfolio losses from any high point along the way. Drawdowns are calculated considering price movements and all distributions paid, if any.

The table below displays the maximum drawdowns of the 100% Fonder med alles. A maximum drawdown is a measure of risk, indicating the largest reduction in portfolio value due to a series of losing trades.

The maximum drawdown for the 100% Fonder med alles was 31.04%, occurring on Jun 30, 2022. Recovery took 684 trading sessions.

The current 100% Fonder med alles drawdown is 4.11%.

The chart below shows the rolling one-month volatility.